10x Genomics, a Pleasenton, Calif.-based company focused on broadening the application of genomic information, closed a $55m Series C financing.
The round was led by Fidelity Management & Research Company with participation from new investors Softbank and JS Capital Management LLC, alongside founding investors Venrock, Foresite Capital, and Paladin Capital.
The company intends to use the funds to accelerate marketing and sales efforts in support of its GemCode™ and Chromium™ products.
Led by Serge Saxonov, Chief Executive Officer, 10x Genomics commercializes a new technology genomics platform that complements and upgrades existing sequencers, delivering new contextual information, including haplotyping, structural variation, other valuable genomic information and de novo assembly, while using existing sequencing technologies and workflows.
FinSMEs
17/03/2016